Oncology Drugs Market Size to Surpass USD 530.39 Billion by 2032, Driven by Advancements in Targeted Therapies and Rising Cancer Incidence – SNS Insider [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
Austin, March 17, 2025 (GLOBE NEWSWIRE) -- Oncology Drugs Market Size & Growth Analysis: According to SNS Insider, the global Oncology Drugs Market was valued at USD 202.30 billion in 2023, is expected to surpass USD 530.39 billion by 2032, growing at a CAGR of 11.34% over the forecast period 2024-2032. This growth is primarily attributed to significant advancements in targeted therapies and an increasing global prevalence of various cancer types. The oncology drugs market has seen significant growth as a result of the increased prevalence of cancer globally, which has fueled greater demand for efficient treatment. Developments in biotechnology have given rise to targeted therapies and immunotherapies, providing more targeted and effe
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie (ABBV) Stock Moves -0.29%: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Factbox-Widely used drugs on US imports list from Europe [Yahoo! Finance]Yahoo! Finance
- Factbox-Widely used drugs on US imports list from Europe [Yahoo! Finance Canada]Yahoo! Finance Canada
- PESG Report: Silexion Therapeutics' Breakthrough Data Shows SIL204's impact on both Primary Tumors & Metastasis – Signaling a Potential Paradigm Shift in Cancer Treatment [Yahoo! Finance]Yahoo! Finance
- AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 1/31/25 - Beat
ABBV
Sec Filings
- 3/18/25 - Form 4
- 3/14/25 - Form 144
- 3/10/25 - Form PRE
- ABBV's page on the SEC website